Hutchmed (HCM) reported 2024 earnings Wednesday of $0.22 per diluted American depositary share, down from $0.58 a year earlier.
Three analysts polled by FactSet expected $0.27.
Revenue for the year ended Dec. 31 was $630.2 million, down from $838 million a year earlier.
Analysts surveyed by FactSet expected $665.9 million.
The company said it had $836.1 million in cash, cash equivalents and short-term investments as of Dec. 31.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.